home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

New AIDS Risk Factor

 
  October, 31 2007 20:38
your information resource in human molecular genetics
 
     
More rapid HIV disease progression occurs in individuals who have a specific genetic risk factor, according to a new study published online in Nature Immunology. A team of HIV researchers led by Sunil Ahuja studied a risk factor that significantly predicts HIV disease outcome. Individuals who have certain combinations of the two genes CCR5 and CCL3L1 are much more likely to have reduced immune responses and greater decline in numbers of CD4+ T immune cells, two hallmarks of progressive HIV disease.

The significance of the findings is two-fold. Previous work indicated that the influence of the two genes was much more limited that the new data indicate. These findings suggest a means to more effectively predict the course of HIV disease.

Author contact:

Sunil Ahuja (University of Texas Health Science Center, San Antonio, TX, USA)
E-mail: AHUJAS@uthscsa.edu

Abstract available online.

(C) Nature Immunology press release.

 


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.